| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/26/1994 | EP0314781B1 Synthesis of glucagon homologs and therapeutic use thereof |
| 01/26/1994 | EP0272304B1 A process for producing a coagulation active complex of factor viii fragments |
| 01/25/1994 | US5281700 Forming coating on luminal surface of the cell membrane, the coating comprising particles of ionic material, forming pellicle adherent to a sheet of the membrane, homogenizing associated tissue, pellicle, and endothelial sheet, separating |
| 01/25/1994 | US5281698 Preparation of an activated polymer ester for protein conjugation |
| 01/25/1994 | US5281697 CEA-binding protein and uses thereof |
| 01/25/1994 | US5281694 Methods and compositions for production of mycoplasmal adhesins |
| 01/25/1994 | US5281693 Pure peptide functioning as calcium channel blocker |
| 01/25/1994 | US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI |
| 01/25/1994 | US5281582 Glycosylated albumin growth factor for tissue treatment |
| 01/25/1994 | US5281581 Treatment of insulin resistance |
| 01/25/1994 | US5281579 Purified virus-free hemoglobin solutions and method for making same |
| 01/25/1994 | US5281577 Inhibitor of the proliferation of herpes viruses and inhibitor of the recurrence of affections caused by their latent infection |
| 01/25/1994 | US5281532 Pseudomas hosts transformed with bacillus endotoxin genes |
| 01/25/1994 | US5281530 Bacterial host transformed to express bacillus thuringiensis nematocidal toxin |
| 01/25/1994 | US5281526 Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof |
| 01/25/1994 | CA1326460C Regulation of cell proliferation and differentiation using peptides |
| 01/25/1994 | CA1326459C Diagnostic peptides of human papilloma virus |
| 01/20/1994 | WO1994028021A1 Endometrial proteins, antigenic compositions and methods for detecting endometriosis |
| 01/20/1994 | WO1994001778A1 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 01/20/1994 | WO1994001777A1 Method of determining metastatic potential of tumor cells |
| 01/20/1994 | WO1994001776A1 Assay for chagas' disease and reagents for its use |
| 01/20/1994 | WO1994001772A1 SCREEN FOR ALZHEIMER'S DISEASE THERAPEUTICS BASED ON β-AMYLOID PRODUCTION |
| 01/20/1994 | WO1994001576A1 Novel flk-2 and analogs |
| 01/20/1994 | WO1994001573A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/20/1994 | WO1994001571A1 Modular promoter construct |
| 01/20/1994 | WO1994001570A1 K. lactis rp28 ribosomal protein gene promoter and use thereof |
| 01/20/1994 | WO1994001569A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 01/20/1994 | WO1994001567A1 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 01/20/1994 | WO1994001563A1 Recombinant dna encoding a desulfurization biocatalyst |
| 01/20/1994 | WO1994001561A1 Gene activating element |
| 01/20/1994 | WO1994001560A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | WO1994001559A2 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
| 01/20/1994 | WO1994001558A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | WO1994001557A1 Bone formation-inducing protein |
| 01/20/1994 | WO1994001556A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | WO1994001555A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | WO1994001553A1 Receptor derivates with binding sites for human rhinoviruses |
| 01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 01/20/1994 | WO1994001548A2 Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001546A1 Elicitor of the hypersensitive response in plants |
| 01/20/1994 | WO1994001533A1 Deletion mutants as vaccines for cholera |
| 01/20/1994 | WO1994001483A1 Biocompatible polymer conjugates |
| 01/20/1994 | WO1994001467A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | WO1994001466A1 Plasma fraction purification |
| 01/20/1994 | WO1994001465A1 New polypeptide |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001463A1 USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS |
| 01/20/1994 | WO1994001462A1 Biologically active polypeptides derived from an actinomycete |
| 01/20/1994 | WO1994001461A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 01/20/1994 | WO1994001460A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 01/20/1994 | WO1994001459A1 A fungicidally active compound |
| 01/20/1994 | WO1994001458A1 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them |
| 01/20/1994 | WO1994001457A1 Interferon receptor binding peptides |
| 01/20/1994 | WO1994001456A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention |
| 01/20/1994 | WO1994001455A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | WO1994001453A1 A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein |
| 01/20/1994 | WO1994001452A1 Process for hemoglobin extraction and purification |
| 01/20/1994 | WO1994001451A2 Method for modification of recombinant polypeptides |
| 01/20/1994 | WO1994001447A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 01/20/1994 | WO1994001139A1 Targeting somatic gene therapy to joints |
| 01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
| 01/20/1994 | WO1994001134A1 Parenteral immunization against rotavirus |
| 01/20/1994 | WO1994001132A1 VACCINE COMPRISING MIXED preS1+preS2+S AND CORE PARTICLE |
| 01/20/1994 | WO1994001131A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | WO1994001130A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | WO1994001120A1 Purification of factor ix |
| 01/20/1994 | WO1994000992A1 Avidin and homologues as larvicides against insect pests |
| 01/20/1994 | WO1994000990A1 Conserved victorin-binding vital protein |
| 01/20/1994 | WO1993023540A3 Improved methods for the preparation of endotoxin-binding proteins |
| 01/20/1994 | CA2140150A1 A major histocompatibility complex antigen for use as vaccine against an immunodeficiency virus |
| 01/20/1994 | CA2140002A1 A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof |
| 01/20/1994 | CA2139945A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor xa |
| 01/20/1994 | CA2139876A1 Recombinant dna encoding a desulfurization biocatalyst |
| 01/20/1994 | CA2139837A1 A fungicidally active compound |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139641A1 Conserved victorin-binding vital protein |
| 01/20/1994 | CA2139573A1 Yeast promoter and its use |
| 01/20/1994 | CA2139572A1 Yeast promoter and its use |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2139500A1 Method of determining metastatic potential of tumor cells |
| 01/20/1994 | CA2139433A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 01/20/1994 | CA2139431A1 Polypeptides having serotoninergie activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | CA2139429A1 Oligopeptide derivatives and their use in secondary cataract prevention |
| 01/20/1994 | CA2139421A1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
| 01/20/1994 | CA2139345A1 New biologically active polypeptides; preparation and use |
| 01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
| 01/20/1994 | CA2137462A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | CA2137242A1 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
| 01/20/1994 | CA2136643A1 Gene activating element |
| 01/20/1994 | CA2135193A1 Novel flk-2 and analogs |
| 01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | CA2118586A1 Transvascular and intracellular delivery of lipidized proteins |
| 01/20/1994 | CA2118585A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | CA2117099A1 Receptor derivatives having binding sites for human rhinoviruses |
| 01/20/1994 | CA2116971A1 Parenteral immunization against rotavirus |
| 01/19/1994 | EP0579363A1 Treatment of tropical spastic paresis with peptide T |
| 01/19/1994 | EP0579360A2 Hyperthermophiles alpha-amylase gene |
| 01/19/1994 | EP0578962A2 Receptor identification method |